Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)

By Kontoghiorghes G.J.   Pattichi K.   Hadjigavriel M.   Kolnagou A.  

Transfusion and Apheresis Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 211-223

Elsevier

Access to resources Recommend Favorite

Iron overload and chelation

By Hershko Chaim   Link Gabriela   Konijn Abraham   Ioav Cabantchik Z.  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 171-173

Maney Publishing

Access to resources Recommend Favorite

Socio-psychological impact of infused iron chelation therapy with deferoxamine in metropolitan France: ISOSFER study results

By Thuret Isabelle   Hacini Maya   Pégourié-Bandelier Brigitte   Gardembas-Pain Martine   Bisot-Locard Ségolène   Merlat-Guitard Annabelle   Bachir Dora  

Hematology, Vol. 14, Iss. 6, 2009-12 ,pp. : 315-322

Maney Publishing

Access to resources Recommend Favorite

The Sydney Children's Hospital experience with the oral iron chelator deferiprone (L1)

By Berdoukas V.   Bohane T.   Eagle C.   Lindeman R.   DeSilva K.   Tobias V.   Painter D.   Fraser I.  

Transfusion and Apheresis Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 239-240

Elsevier

Access to resources Recommend Favorite

Competition studies of L1-deferiprone with copper and iron. Possible implications on efficacy, toxicity and new therapeutic applications

By Pashalidis I.   Kontoghiorghes G.J.  

Transfusion and Apheresis Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 259-261

Elsevier

Access to resources Recommend Favorite